咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 临床医学

主题

  • 1 篇 mutation
  • 1 篇 lung
  • 1 篇 eml4-alk
  • 1 篇 gene
  • 1 篇 histology
  • 1 篇 cancer
  • 1 篇 egfr

机构

  • 1 篇 oncology departm...
  • 1 篇 oncotest-teva te...
  • 1 篇 sharett institut...
  • 1 篇 pulmonary-oncolo...

作者

  • 1 篇 addie dvir
  • 1 篇 lior soussan-gut...
  • 1 篇 hovav nechushtan
  • 1 篇 jair bar
  • 1 篇 amir onn
  • 1 篇 maya ilouze
  • 1 篇 nir peled
  • 1 篇 maya gottfried
  • 1 篇 haim biran
  • 1 篇 dekel shlomi

语言

  • 1 篇 英文
检索条件"作者=Dekel Shlomi"
1 条 记 录,以下是1-10 订阅
排序:
Better Selection Model for EML4-ALK Fusion Gene Test in Patients with Non-Small-Cell Lung Cancer
收藏 引用
Journal of Cancer Therapy 2013年 第8期4卷 54-58页
作者: dekel shlomi Amir Onn Maya Gottfried Jair Bar Haim Biran Maya Ilouze Addie Dvir Hovav Nechushtan Lior Soussan-Gutman Nir Peled Oncology Department Meir Medical Center Kfar Saba Israel Oncotest-TEVA Teva Pharmaceutical Industries LTD. Shoham Israel Pulmonary-Oncology Unit Chaim Sheba Medical Center Tel Hashomer Israel Sharett Institute of Oncology Hadassah He- brew University Medical Center Jerusalem Israel.
Background: In the last decade, the search for gene mutations in lung cancer has been constantly growing. EGFR, KRAS mutations and, recently, the EML4-ALK fusion can guide the selection of treatment for patients who c... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论